Furthermore, Herceptin, also known as trastuzumab, a medication targeting HER-2 in breast cancer treatment, was found to elevate mitochondrial ROS levels in rat cardiomyocytes while reducing GPX4 expression, thereby leading to ferroptosis. Here, ERBB2 is linked to breast cancer.